卡巴培南类抗生素市场基于(主要地区、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00027228
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

Carbapenem-Based Antibiotics Market Size | Report 2021, 2028

Buy Now

卡巴培南抗生素市场规模预计将从 2021 年的 39.6457 亿美元增长到 2028 年的 53.4662 亿美元;预计 2021-2028 年期间的复合年增长率为4.4 %。

卡巴培南类抗生素是一种非典型β-内酰胺类抗生素,具有更广泛的抗菌活性。基于卡巴培南类的抗生素可以覆盖许多革兰氏阳性菌、革兰氏阴性需氧菌和厌氧菌。此外,基于卡巴培南类的抗生素对大多数β-内酰胺酶稳定。因此,它们被用作各种严重疾病的经验性单一疗法,例如中性粒细胞减少性感染和腹腔内感染。


革兰氏阴性细菌感染的患病率不断上升,仿制药产量不断增加,推动了卡巴培南类抗生素市场的增长。然而,抗生素开发过程繁琐且昂贵,限制了市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

卡巴培南类抗生素市场:

Carbapenem-Based Antibiotics Market: Strategic Insights

Carbapenem-Based Antibiotics Market

  • CAGR (2021 - 2028)
    4.4%
  • Market Size 2021
    US$ 3.96 Billion
  • Market Size 2028
    US$ 5.35 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Pfizer Inc.
  • Savior Lifetec
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Merck & Co., Inc.
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • Daewoong Pharmaceutical Co.,Ltd,
  • Iterum Therapeutics plc
  • ACS Dobfar S.p.A

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

类型(美罗培南、多利培南、亚胺培南、替比培南等)
    适应症(细菌性脑膜炎、急性盆腔感染、呼吸道感染、腹腔内感染、泌尿道感染等)
      分销渠道(零售药店、网上药店和医院药店)

        卡巴培南类抗生素市场

        • 复合年增长率(2021 - 2028 年)
          4.4%
        • 2021 年市场规模
          39.6 亿美元
        • 2028 年市场规模
          53.5 亿美元

        市场动态

        增长动力
        • 財政部
        • 財政部
        • 財政部
        未来的趋势
        • 財政部
        • 財政部
        • 財政部
        机会
        • 財政部
        • 財政部
        • 財政部

        关键人物;主力;重要一员

        •  
        • 辉瑞公司
        • Savior Lifetec
        • 住友 大日本 制药株式会社
        • 默克公司
        • 格兰特制药有限公司
        • 阿拉宾多制药有限公司
        • 大熊制药有限公司
        • Iterum Therapeutics plc
        • ACS多布法尔公司

        区域概况

        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        类型
        • 美罗培南
        • 多利培南
        • 亚胺培南
        • 替比培南
        • 其他的
        指征
        • 细菌性脑膜炎
        • 急性盆腔感染
        • 呼吸道感染
        • 腹腔内感染
        • 泌尿道感染
        • 其他的
        分销渠道
        • 零售药店
        • 网上药店
        • 医院药房
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

        市场洞察
        革兰氏阴性细菌感染患病率上升

        革兰氏阴性细菌感染,例如尿路感染 (UTI)、肺炎、血流感染、伤口或手术部位感染以及脑膜炎,通常是患者在住院期间感染的。这些感染通常被称为医院内感染 (HAI)。尿路感染和肺炎等感染在重症监护病房的患者中很常见。根据美国国家医疗保健安全网络的数据,30% 的医院内感染是由革兰氏阴性细菌引起的,约 45% 是由尿路感染引起的,约 47% 是由呼吸机相关性肺炎 (VAP) 引起的。革兰氏阴性细菌引起的传染病的患病率正在迅速上升。

        此外,革兰氏阴性细菌感染对多种药物具有耐药性,并且对现有抗生素产生了更好的耐药性。抗菌素耐药性 (AMR) 已成为现代医学的全球威胁。因此,需要不断监测临床分离株的新趋势。欧洲拉脱维亚的一组研究人员研究了不同革兰氏阴性细菌的 AMR 进展。根据他们于 2021 年 6 月在 MDPI 期刊上发表的研究文章,美罗培南和厄他培南等基于卡巴培南的抗生素对革兰氏阴性细菌最有效,耐药率分别为 3% 和 5.4%。这些抗生素被全球接受为治疗革兰氏阴性细菌的方法。因此,据估计,未来几年对基于卡巴培南的抗生素的高需求可能会持续下去。

        根据美国疾病控制与预防中心 (CDC) 的数据,COVID-19 疫情导致 2020 年 HAI 病例增加。全球住院人数增加,这增加了 COVID-19 患者感染 VAP 的风险。这导致对卡巴培南类抗生素的需求激增,从而极大地促进了市场发展。

        基于类型的洞察

        卡巴培南类抗生素市场按类型分为美罗培南、多利培南、亚胺培南、替比培南和其他。其他类别在 2021 年占据卡巴培南类抗生素市场的最大份额,预计在预测期内将实现市场最高复合年增长率。卡巴培南类抗生素的不断发展可能会推动未来市场的增长。

         

        基于指示的见解

        根据适应症,卡巴培南类抗生素市场细分为细菌性脑膜炎、急性盆腔感染、呼吸道感染、腹腔内感染、泌尿道感染等。其他部分在 2021 年占据卡巴培南类抗生素市场的最大份额,预计在预测期内将实现市场最高复合年增长率。细菌感染的不确定性推动了对卡巴培南类抗生素的需求,预计这将在未来几年推动市场增长。

         

        卡巴培南类抗生素市场报告范围

        报告属性细节
        2021 年市场规模39.6亿美元
        2028 年市场规模53.5亿美元
        全球复合年增长率(2021 - 2028)4.4%
        历史数据2019-2020
        预测期2022-2028
        涵盖的领域按类型
        • 美罗培南
        • 多利培南
        • 亚胺培南
        • 替比培南
        • 其他的
        按适应症
        • 细菌性脑膜炎
        • 急性盆腔感染
        • 呼吸道感染
        • 腹腔内感染
        • 泌尿道感染
        • 其他的
        按分销渠道
        • 零售药店
        • 网上药店
        • 医院药房
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        •  
        • 辉瑞公司
        • Savior Lifetec
        • 住友大日本制药株式会社
        • 默克公司
        • 格兰特制药有限公司
        • 阿拉宾多制药有限公司
        • 大熊制药有限公司
        • Iterum Therapeutics plc
        • ACS多布法尔公司
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

        基于分销渠道的洞察

        根据分销渠道,卡巴培南类抗生素市场分为零售药店、网上药店和医院药店。2021 年,医院药店占据卡巴培南类抗生素市场的最大份额,预计在预测期内将录得市场最高复合年增长率。

         

        公司通常采用有机策略(例如新产品发布)来扩大其在市场上的产品组合。此外,公司还实施了各种无机策略,例如并购和合作。例如,2021 年 5 月,Gland Pharma Limited 与 Dr Reddy's Laboratories Ltd 合作推出了注射用厄他培南 1 g/瓶,其治疗效果相当于美国食品药品监督管理局 (USFDA) 批准的 INVANZ(注射用厄他培南)1 g/瓶的仿制药。

         

        公司简介

        • 辉瑞公司
        • Savior Lifetec
        • 住友大日本制药株式会社
        • 默克公司
        • 格兰特制药有限公司
        • 阿拉宾多制药有限公司
        • 大熊制药株式会社
        • Iterum Therapeutics plc
        • ACS多布法尔公司
        • Spero治疗公司

        Carbapenem-Based Antibiotics Market Report Scope

        Report Attribute Details
        Market size in US$ 3.96 Billion
        Market Size by US$ 5.35 Billion
        Global CAGR 4.4%
        Historical Data 2019-2020
        Forecast period 2022-2028
        Segments Covered By 类型(美罗培南、多利培南、亚胺培南、替比培南等)
        By 适应症(细菌性脑膜炎、急性盆腔感染、呼吸道感染、腹腔内感染、泌尿道感染等)
        By 分销渠道(零售药店、网上药店和医院药店)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Pfizer Inc.
      • Savior Lifetec
      • Sumitomo Dainippon Pharma Co., Ltd.
      • Merck & Co., Inc.
      • Gland Pharma Limited
      • Aurobindo Pharma Ltd
      • Daewoong Pharmaceutical Co.,Ltd,
      • Iterum Therapeutics plc
      • ACS Dobfar S.p.A
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        Frequently Asked Questions


        Which segment is dominating the carbapenem-based antibiotics market?

        The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.

        Who are the major players in market the carbapenem-based antibiotics market?

        The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.

        What are the carbapenem-based antibiotics?

        Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.

        What are the driving factors for the global carbapenem-based antibiotics market across the world?

        The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.

        The List of Companies - Carbapenem Based Antibiotics Market

        1. Pfizer Inc.
        2. Savior Lifetec
        3. Sumitomo Dainippon Pharma Co., Ltd.
        4. Merck & Co., Inc.
        5. Gland Pharma Limited
        6. Aurobindo Pharma Ltd
        7. Daewoong Pharmaceutical Co.,Ltd,
        8. Iterum Therapeutics plc
        9. ACS Dobfar S.p.A
        10. Spero Therapeutics

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Related Reports